Treatment of Post-Stroke Depression

Screening and Diagnosis

The American Heart Association recommends administration of a structured depression inventory, such as the Patient Health Questionnaire-2, to routinely screen for post-stroke depression in patients who have had a stroke 1, 2
Periodic reassessment of depression, anxiety, and other psychiatric symptoms is useful in the care of stroke survivors, as recommended by the American Heart Association 1, 3
Consultation by a qualified psychiatrist or psychologist is useful for stroke survivors with mood disorders causing persistent distress or worsening disability, according to the American Heart Association 1

The American College of Physicians recommends SSRIs and SNRIs as the first-line pharmacological treatments for post-stroke depression 4, 5, 6
Patients diagnosed with post-stroke depression should be treated with antidepressants in the absence of contraindications and closely monitored to verify effectiveness, as recommended by the American Heart Association 1, 2
The American Heart Association suggests that no specific recommendation is made for any particular class of antidepressants, though SSRIs are commonly used and generally well tolerated in stroke patients 1, 3
Prophylactic use of antidepressants for prevention of post-stroke depression is not recommended due to risk of fractures and other adverse events, according to the American College of Physicians 4, 5, 6

The American College of Physicians recommends psychotherapy, particularly cognitive behavioral therapy (CBT), for treatment of post-stroke depression 4, 5, 6
Mindfulness-based therapies are suggested for treatment of depression following stroke, as recommended by the American College of Physicians 4, 5, 6
Patient education about stroke is recommended, with patients receiving information, advice, and opportunities to discuss the impact of illness on their lives, according to the American Heart Association 1, 2
An exercise program of at least 4 weeks duration may be considered as a complementary treatment for post-stroke depression, as suggested by the American Heart Association 1, 3

Combining pharmacological and non-pharmacological treatments may be considered, though evidence for the superiority of combination therapy is limited, according to the American Heart Association 1, 2
Early effective treatment of depression may have a positive effect on rehabilitation outcomes, as recommended by the American Heart Association 1, 3

The efficacy of individual psychotherapy alone in the treatment of post-stroke depression remains unclear, according to the American Heart Association 1
There is insufficient evidence to recommend for or against acupuncture, either alone or as an adjunct to pharmacotherapy, for depression following stroke, as stated by the American College of Physicians 4, 5, 6
Effective treatment of post-stroke depression is associated with improved functional recovery and potentially longer survival among stroke survivors, according to the American Heart Association 1, 2
Treatment should be closely monitored by an appropriately trained healthcare professional, as some antidepressants may increase risk of bleeding or intracerebral hemorrhage, as recommended by the American Heart Association 7

Anxiety frequently coexists with post-stroke depression and should be assessed and treated concurrently, according to research published in Stroke 8
The U.S. Department of Veterans Affairs and Department of Defense provide a "weak for" recommendation for SSRIs or SNRIs for depression symptoms following stroke, as stated in the Annals of Internal Medicine 9
The World Stroke Organization notes that while some guidelines recommend SSRIs for post-stroke depression, the evidence is not universally considered strong, as reported in the International Journal of Stroke 10

The U.S. Department of Veterans Affairs and Department of Defense guidelines also support the use of SSRIs or SNRIs, with a recommendation based on evidence from the Annals of Internal Medicine 11

Sertraline has been extensively studied in cardiovascular disease and appears to be safe with a lower risk of QTc prolongation compared to other SSRIs like citalopram or escitalopram, according to the American Heart Association guidelines 12

For stroke patients requiring sertraline, the American College of Cardiology recommends continuing treatment for at least 6 weeks to assess full antidepressant effect, with a standard starting dose of 50 mg daily and titration to 100-200 mg daily based on clinical response over 2-4 weeks 12

The American Heart Association/American Stroke Association guidelines, supported by a Cochrane review of 75 studies including 5,907 participants, demonstrate that SSRIs reduce the proportion of patients with post-stroke depression (RR 0.75) with high-quality evidence 13, 14

Tricyclic antidepressants (TCAs) should be avoided in stroke patients because they can provoke orthostatic hypotension, worsening of heart failure, and arrhythmias, and monoamine oxidase inhibitors (MAOIs) can cause hypertension 15

Watch for QTc interval prolongation, particularly with certain antidepressants, which can predispose to ventricular tachycardia 15

Cognitive behavioral therapy (CBT) should be offered alongside pharmacotherapy, as the combination may enhance outcomes, though evidence for superiority of combination therapy over monotherapy is limited 13, 14

The American Heart Association/American Stroke Association 2022 explicitly states that there is insufficient evidence to recommend tDCS in stroke rehabilitation, including for mood disorders 16, 17, 18
The VA/DoD 2024 guideline gives a "neither for nor against" recommendation for non-invasive brain stimulation (including tDCS and repetitive transcranial magnetic stimulation) in patients undergoing stroke rehabilitation 16, 17

The American College of Physicians recommends SSRI (selective serotonin reuptake inhibitor) or SNRI (serotonin norepinephrine reuptake inhibitor) as first-line pharmacological therapy for post-stroke depression 16, 17
Cognitive behavioral therapy (CBT) is recommended as an effective therapy for post-stroke depression 16, 17

The American Heart Association/American Stroke Association recommends using validated screening tools: Patient Health Questionnaire-9 (PHQ-9), Hamilton Depression Rating Scale, or Beck Depression Inventory 19, 20

The American Stroke Association notes that SSRI should be used with caution in patients with a history of intracerebral hemorrhage (ICH) due to a small increased risk of rebleeding 18, 19
The American College of Physicians advises against using antidepressant prophylaxis in patients without depression due to the risk of fractures and other side effects 16, 17